NCT07779967

Brief Summary

Alcohol consumption, even at low levels, has been associated with increased breast cancer risk, but the biological mechanisms underlying this relationship remain unclear. This study will examine whether breast tissue may locally metabolize alcohol by measuring alcohol-related compounds in paired blood and breast milk samples from lactating women. The findings may help clarify alcohol-related biological pathways relevant to breast cancer risk and improve risk communication.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
66mo left

Started Sep 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Sep 2026Mar 2032

First Submitted

Initial submission to the registry

August 18, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 21, 2026

Completed
13 days until next milestone

Study Start

First participant enrolled

September 3, 2026

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2031

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2032

Last Updated

September 8, 2026

Status Verified

September 1, 2026

Enrollment Period

4.9 years

First QC Date

August 18, 2026

Last Update Submit

September 2, 2026

Conditions

Keywords

lactatingwomenalcoholethanolmetabolismbreastmilk

Outcome Measures

Primary Outcomes (4)

  • Blood alcohol concentrations

    Alcohol concentrations in blood

    2- 3 weeks

  • Milk alcohol concentration

    Concentration of alcohol in breast milk

    2- 3 weeks

  • Milk acetaldehyde

    Concentration of acetaldehyde in human milk

    1-3 weeks

  • Blood acetaldehyde

    Concentration of acetaldehyde in blood

    1- 3 weeks

Study Arms (3)

Arm 1: lactating women dose response

EXPERIMENTAL

Lactating women who will drink \~0, 1 or 2 standard drinks of alcohol

Other: Low-alcohol level exposure

Arm 2: timing of pumping

EXPERIMENTAL

Lactating women will pump at two different times from alcohol drinking and at one of these times after placebo drinking

Other: Breast-pumping time

Aim 3: non-lactating control women

OTHER

Non-lactating women of similar age, BMI, and alcohol consumption characteristics will drink a similar dose of alcohol as lactating women for the assessment of systemic alcohol-related measurements. This group will serve as a comparison group for interpreting alcohol-related measurements in lactating participants.

Other: Low-alcohol level exposure

Interventions

Participants will consume a protocol-specified low-level alcohol exposure under study conditions. The assigned dose and biospecimen collection procedures will vary by study group.

Aim 3: non-lactating control womenArm 1: lactating women dose response

Breast pumping before or after drinking \~ 1 standard drink or placebo drink

Arm 2: timing of pumping

Eligibility Criteria

Age21 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All aims
  • Drink alcohol (at least one alcoholic drink during lactation of a lactating female)
  • For aims 1 and 2
  • Nursing a 2- to 5-month-old infant
  • Experienced with a breast pump

You may not qualify if:

  • Pregnant
  • Lifetime history of alcohol dependence
  • Drink more than 3 standard drinks per day or more than 7 standard drinks per week in the month previous to enrollment
  • Current regular use of drugs with addiction potential (other than alcohol)
  • Use of medications known to interact with alcohol metabolism
  • Current smoking
  • Anemia
  • Diabetes
  • Liver disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bevier Hall; University of Illinois at Urbana Champaign

Urbana, Illinois, 61801, United States

RECRUITING

MeSH Terms

Conditions

Alcohol DrinkingBreast Feeding

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Drinking BehaviorBehaviorFeeding Behavior

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Marta Y Pepino de Gruev

    University of Illinois at Urbana-Champaign

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marta Y Pepino de Gruev, Ph D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Aim 1: lactating women will be assessed with two doses of alcohol ; Aim 2, lactating women will be assessed with one dose of alcohol with varying breast pumping times; Aim 3 non-lactating women will be assessed with one dose of alcohol with varying blood sample sites (arterialized vs vein).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2026

First Posted

August 21, 2026

Study Start

September 3, 2026

Primary Completion (Estimated)

July 13, 2031

Study Completion (Estimated)

March 1, 2032

Last Updated

September 8, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

* De-identified participant demographic and screening variables (e.g., age, BMI, lactation characteristics) * Alcohol dosing information based on measured fat-free mass * Time-resolved physiological and pharmacokinetic data (e.g., blood alcohol concentration, breath alcohol concentration, elimination rates, AUC) * Quantitative biochemical measurements of ethanol and acetaldehyde concentrations in paired human milk and blood samples obtained using headspace gas chromatography with flame ionization detection (HS-GC-FID) * Derived variables generated for statistical and pharmacokinetic analyses

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
From the end of the grant until NIAAA Da allows it.
Access Criteria
The data will be shared with NIAAA DA and they will determine the protocol to access.
More information

Locations